Clinical trial · Observational
Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors
NCT06634381CI-TRIAL-00119338VAPrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this research study is to better understand how cancer-related fatigue affects patients and how it's discussed with providers. This information will be used to develop an educational resource (visual aid poster) that could help individuals and their providers talk about cancer-related fatigue and which may help individuals better manage this symptom.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Fatigue | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CRF Visual Aid | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Survivors
- description
- Cancer survivors with any type of cancer and a history of at least 1 visit for the purpose of monitoring long term care post curative treatment at LCH and/or the Charlotte or Winston-Salem campuses of AHWFBCCC who have completed curative treatment for more than 6 months.
- interventionNames
- Behavioral: CRF Visual Aid
- label
- Clinicians
- description
- Any providers working with post-treatment oncology survivors at LCH and the Charlotte or Winston Salem campuses of AHWFBCCC.
- interventionNames
- Behavioral: CRF Visual Aid
Primary outcomes (1)
- measure
- Domains reflecting cancer-related fatigue (CRF) experiences in cancer survivors
- timeFrame
- Seven months from baseline
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Ability to comply with study procedures for the duration of the study Survivors: * Written informed consent and HIPAA authorization for release of personal information * Ability to read/write, understand and converse in English without the need for an interpreter * Men and women aged ≥ 18 years at the time of consent * History of at least one visit for the purpose of monitoring long term care post curative treatment at LCH and/or the Charlotte or Winston-Salem campuses of AHWFBCCC * Completed curative treatment \> 6 months ago for any cancer type, with no detectable evidence of cancer * Self-reported tiredness, exhaustion, or weakness (i.e. fatigue) score of ≥ 4 on the Numerical Rating Scale * Adjuvant endocrine therapy to reduce the risk of cancer returning is acceptable (i.e. tamoxifen or aromatase inhibitors). Clinicians: \- Currently see oncology patients (any cancer type) for survivorship care at LCH and/or the Charlotte or Winston-Salem campuses of AHWFBCCC Exclusion Criteria: Survivors: * Continuing maintenance therapy or other cancer-related treatment (i.e. immunotherapy) * History of or current untreated Major Depressive Disorders or untreated severe depression * Hemoglobin \<11g/dL at last CBC SOC lab collection * History/diagnosis of dementia * Factors or conditions, for which participation may (1) not be in the best interest or (2) interfere with study assessment results (e.g. medical comorbidities, primary brain tumor/metastases) * No access to internet/Wi-Fi Clinicians: \- None
References
Publications (0)
Data not yet available
No reference posted for this study.